Lumos Pharma
Manufacturing · Texas, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
4200 Marathon Blvd Ste 200, Austin, Texa...Phone Number
(512) 215-2630Website
www.lumos-pharma.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About Lumos Pharma
Lumos Pharma is a clinical-stage biopharmaceutical company whose mission is to develop new therapies for people with rare diseases, prioritizing its focus where the medical need is high, and the pathophysiology is clear. We are committed to this mission and a strategy that is grounded upon time and cost-efficient drug development to deliver safe and effective therapies to patients.Explore more
Lumos Pharma Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Lumos Pharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Lumos Pharma had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Lumos Pharma, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Lumos Pharma
Earning: See what the market has to say on Lumos Pharma recently announced quarterly report
Check if Lumos Pharma has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Lumos Pharma has new funding data
Check out if Lumos Pharma is spiking on competitors!
Product Launch: Get notified when Lumos Pharma launches new products
Recommended Actions
Find VP level buyers at Lumos Pharma
Find 3 more new buyers
Compare Similar Companies to Lumos Pharma
Compare insights from companies similar to Lumos Pharma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Lumos Pharma is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Lumos Pharma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Lumos Pharma.
Lumos Pharma financials insights
Gather financial insights about Lumos Pharma, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2014
Series A
$13M
2016
Series B
$34M
Lumos Pharma Tech Stack
A closer look at the technologies used by Lumos Pharma
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Mergers & Acquisitions (M&A)
Mergers & Acquisitions, Acquisitions, Mergers
Earnings
Lumos Pharma has recently released 2024 Q1 report with the following insight: Trial execution risks, including ability to enroll trial on timelines. Mitigation strategies in place to expand trial globally.
Earnings
Lumos Pharma has recently released 2024 Q1 report with the following insight: Currently no funds to finance Phase 3 trial, but confidence is high that financing can be secured.
Financial Planning, Funding
Earnings
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Lumos Pharma
Sign Up For FreeTo access detailed company insights
Lumos Pharma is a clinical-stage biopharmaceutical company whose mission is to develop new therapies for people with rare diseases, prioritizing its focus where the medical need is high, and the pathophysiology is clear. We are committed to this mission and a strategy that is grounded upon time and cost-efficient drug development to deliver safe an... Read More
